Bakken Trine Lise, Sandberg Magnus, Axmon Anna
Mental Health Addiction, Oslo University Hospital, Oslo, Norway.
Health Sciences, Oslo Metropolitan University, Oslo, Norway.
Gen Psychiatr. 2024 Dec 12;37(6):e101673. doi: 10.1136/gpsych-2024-101673. eCollection 2024.
The knowledge about the prevalence of schizophrenia among people with intellectual disabilities (ID) is sparse, particularly concerning the distribution in different age groups.
To investigate the prevalence of diagnoses in the schizophrenia spectrum among people with ID compared with the general population (gPop).
This was an 8-year longitudinal register study. The participants were all residents of Skåne on 1 January 2014. People with a diagnosis of ID (F7 in International Statistical Classification of Diseases and Related Health Problems 10th Revision) or Down syndrome (DS; Q90), or service and support for people with ID/autism spectrum disorder (ASD) comprised the ID cohort (n=14 716). After excluding family members of people in the ID cohort, the remaining population of Skåne comprised the gPop cohort (n=1 226 955).The primary outcome measure was having at least one diagnosis in the schizophrenia spectrum (F20-F29). Secondary outcomes were single diagnoses within the schizophrenia spectrum.
The prevalence of schizophrenia spectrum diagnoses was 7.2% in the ID cohort. This was more than an eightfold increase compared with the gPop (relative risk (RR) 8.45; 95% CI 7.94 to 9.00). The risk was also high among children (aged 0-18 years at the start of the study period; RR 9.42; 95% CI 7.36 to 12.05). In the subcohort comprising those with a diagnosis of DS, the risk of schizophrenia diagnosis was more than twice as high as in gPop. Concomitant ASD or genetic syndrome did not carry an excess risk among people with ID when compared with the gPop.
The findings of the present study support earlier assumptions that people with vulnerable brains develop psychotic disorders more frequently and that the onset age is lower than among people in the gPop. Habilitation services for children and adolescents, as well as general mental health services, should keep in mind that schizophrenia may be present when children and adolescents show severely decreased functioning, anxiety or aggressive behaviour.
关于智力残疾(ID)人群中精神分裂症患病率的了解较为匮乏,尤其是不同年龄组的分布情况。
调查与普通人群(gPop)相比,ID人群中精神分裂症谱系诊断的患病率。
这是一项为期8年的纵向登记研究。参与者为2014年1月1日斯坎尼亚的所有居民。诊断为ID(国际疾病分类第10版中的F7)或唐氏综合征(DS;Q90)的人群,或为ID/自闭症谱系障碍(ASD)患者提供服务和支持的人群组成ID队列(n = 14716)。排除ID队列中人员的家庭成员后,斯坎尼亚的其余人群组成gPop队列(n = 1226955)。主要结局指标是在精神分裂症谱系中至少有一项诊断(F20 - F29)。次要结局是精神分裂症谱系内的单一诊断。
ID队列中精神分裂症谱系诊断的患病率为7.2%。与gPop相比,这一患病率增加了八倍多(相对风险(RR)8.45;95%置信区间7.94至9.00)。在儿童中(研究期开始时年龄为0 - 18岁)风险也很高(RR 9.42;95%置信区间7.36至12.05)。在包括诊断为DS的人群的亚队列中,精神分裂症诊断的风险是gPop中的两倍多。与gPop相比,ID人群中合并ASD或遗传综合征并未带来额外风险。
本研究结果支持了早期的假设,即大脑脆弱的人群更频繁地发生精神障碍,且发病年龄低于gPop人群。儿童和青少年的康复服务以及一般心理健康服务应牢记,当儿童和青少年功能严重下降、出现焦虑或攻击行为时,可能存在精神分裂症。